| abstract |
Use of CDP-choline or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the prophylaxis of cerebral ischemia, wherein CDP-choline or a pharmaceutically acceptable salt thereof is administered to patients at high risk of acute ischemic episode prior to the possible onset of ischemic episode. the risk is due to risk factors from the group, including a history of ischemic episodes, increased arterial blood pressure, hypercholesterolemia, smoking, atrial fibrillation, and other embolic heart disease. |